These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 8584620)

  • 1. Comparison of cytotoxicity of a quaternary pyridinium metabolite of haloperidol (HP+) with neurotoxin N-methyl-4-phenylpyridinium (MPP+) towards cultured dopaminergic neuroblastoma cells.
    Fang J; Zuo D; Yu PH
    Psychopharmacology (Berl); 1995 Oct; 121(3):373-8. PubMed ID: 8584620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a quaternary pyridinium metabolite of haloperidol (HP+) on the viability and catecholamine levels of cultured PC12 cells.
    Fang J; Yu PH
    Can J Physiol Pharmacol; 1997 Aug; 75(8):996-1000. PubMed ID: 9360014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-Methyl-4-phenylpyridinium-like neurotoxicity of a pyridinium metabolite derived from haloperidol: cell culture and neurotransmitter uptake studies.
    Bloomquist J; King E; Wright A; Mytilineou C; Kimura K; Castagnoli K; Castagnoli N
    J Pharmacol Exp Ther; 1994 Aug; 270(2):822-30. PubMed ID: 8071874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine transporter expression confers cytotoxicity to low doses of the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium.
    Pifl C; Giros B; Caron MG
    J Neurosci; 1993 Oct; 13(10):4246-53. PubMed ID: 8410185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catecholamine transporters and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: studies comparing the cloned human noradrenaline and human dopamine transporter.
    Pifl C; Hornykiewicz O; Giros B; Caron MG
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1437-43. PubMed ID: 8667208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model of chronic neurotoxicity: long-term retention of the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) within catecholaminergic neurons.
    Johannessen JN
    Neurotoxicology; 1991; 12(2):285-302. PubMed ID: 1956587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential Extracellular Generation of the Active Parkinsonian Toxin MPP+ by Transporter-Independent Export of the Intermediate MPDP+.
    Schildknecht S; Pape R; Meiser J; Karreman C; Strittmatter T; Odermatt M; Cirri E; Friemel A; Ringwald M; Pasquarelli N; Ferger B; Brunner T; Marx A; Möller HM; Hiller K; Leist M
    Antioxid Redox Signal; 2015 Nov; 23(13):1001-16. PubMed ID: 26413876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-Methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (salsolinol) is toxic to dopaminergic neuroblastoma SH-SY5Y cells via impairment of cellular energy metabolism.
    Storch A; Kaftan A; Burkhardt K; Schwarz J
    Brain Res; 2000 Feb; 855(1):67-75. PubMed ID: 10650131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MPP(+)-like neurotoxicity of a pyridinium metabolite derived from haloperidol: in vivo microdialysis and in vitro mitochondrial studies.
    Rollema H; Skolnik M; D'Engelbronner J; Igarashi K; Usuki E; Castagnoli N
    J Pharmacol Exp Ther; 1994 Jan; 268(1):380-7. PubMed ID: 8301579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-neurotoxicity trends of analogues of 1-methyl-4-phenylpyridinium (MPP+), the cytotoxic metabolite of the dopaminergic neurotoxin MPTP.
    Arora PK; Riachi NJ; Fiedler GC; Singh MP; Abdallah F; Harik SI; Sayre LM
    Life Sci; 1990; 46(5):379-90. PubMed ID: 2304377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute Restraint Stress Augments 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Neurotoxicity via Increased Toxin Uptake into the Brain in C57BL/6 Mice.
    Mitsumoto Y; Mori A
    Neurosci Bull; 2018 Oct; 34(5):849-853. PubMed ID: 29987518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of the degeneration of human dopaminergic neurons in an astrocyte co-culture system allowing endogenous drug metabolism.
    Efremova L; Schildknecht S; Adam M; Pape R; Gutbier S; Hanf B; Bürkle A; Leist M
    Br J Pharmacol; 2015 Aug; 172(16):4119-32. PubMed ID: 25989025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of [14C]MPTP in mouse and monkey implicates MPP+, and not bound metabolites, as the operative neurotoxin.
    Yang SC; Johannessen JN; Markey SP
    Chem Res Toxicol; 1988; 1(4):228-33. PubMed ID: 2979736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secalonic acid A protects dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP⁺)-induced cell death via the mitochondrial apoptotic pathway.
    Zhai A; Zhu X; Wang X; Chen R; Wang H
    Eur J Pharmacol; 2013 Aug; 713(1-3):58-67. PubMed ID: 23665112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetaldehyde directly enhances MPP+ neurotoxicity and delays its elimination from the striatum.
    Zuddas A; Corsini GU; Schinelli S; Barker JL; Kopin IJ; di Porzio U
    Brain Res; 1989 Oct; 501(1):11-22. PubMed ID: 2804689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine transporter-mediated cytotoxicity of beta-carbolinium derivatives related to Parkinson's disease: relationship to transporter-dependent uptake.
    Storch A; Hwang YI; Gearhart DA; Beach JW; Neafsey EJ; Collins MA; Schwarz J
    J Neurochem; 2004 May; 89(3):685-94. PubMed ID: 15086525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and disposition of 1-methyl-4-phenylpyridinium in primary cultures of mouse astrocytes.
    Di Monte DA; Wu EY; Irwin I; Delanney LE; Langston JW
    Glia; 1992; 5(1):48-55. PubMed ID: 1311704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dopaminergic neurotoxin MPTP/MPP+ on coenzyme Q content.
    Dhanasekaran M; Karuppagounder SS; Uthayathas S; Wold LE; Parameshwaran K; Jayachandra Babu R; Suppiramaniam V; Brown-Borg H
    Life Sci; 2008 Jul; 83(3-4):92-5. PubMed ID: 18565546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in neuronal dopamine homeostasis following 1-methyl-4-phenylpyridinium (MPP+) exposure.
    Choi SJ; Panhelainen A; Schmitz Y; Larsen KE; Kanter E; Wu M; Sulzer D; Mosharov EV
    J Biol Chem; 2015 Mar; 290(11):6799-809. PubMed ID: 25596531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesencephalic dopamine neurons become less sensitive to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity during development in vitro.
    Danias P; Nicklas WJ; Ofori S; Shen J; Mytilineou C
    J Neurochem; 1989 Oct; 53(4):1149-55. PubMed ID: 2788714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.